Main Page Image
Description
What's new and exciting in ATTR cardiac amyloidosis 2024 Webinar - April 29th - 3:00 pm ET
Join Dr. Fredrick Ruberg and Dr. Omar Siddiqi as they discuss the general overview of ATTR treatment with new developments over the past year (APOLLO-B, ATTRibute-CM), currently enrolled trials (HELIOS-B, CARDIO-TTRansform), and future trials (DepleTTR-CM, MAGNITUDE). They will also cover current heart failure therapy updates (SGLT2i) and imaging (evuzamitide). Following the presentation, there will be a live Q & A session to answer any questions.
* This webinar will be recorded and posted on the website the first week in May.
Start Date&Time
End date&time
Location
Online
Contact Email